Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Morrie M. Gelfand"'
Autor:
M Corinne Devlin, Douglas S Hepburn, Morrie M. Gelfand, Wilfred M Steinberg, Jacques E. Rioux
Publikováno v:
Menopause (New York, N.Y.). 25(11)
The efficacy and safety of 25-microg 17beta-estradiol vaginal tablets (Vagifem) were assessed and compared with 1.25-mg conjugated equine estrogen vaginal cream (Premarin Vaginal Cream) for the relief of menopausal-derived atrophic vaginitis, resulti
Autor:
Michael C. Klein, Morrie M. Gelfand, Valmai Elkins, Michael Kramer, Ruta Westreich, Apostolo Papageorgiou, Liliane Spector-Dunsky
Publikováno v:
Santé mentale au Québec. 8:47-54
Distribués au hasard, deux groupes de couples cnt été comparés quant à leur sentiment de satisfaction à l'égard de la naissance de leur enfant. Le groupe O.N. a fait usage de la chambre de naissance, tandis que le groupe C.T., a utilisé la ch
Autor:
Morrie M. Gelfand
Publikováno v:
Menopause. 11:505-507
Autor:
Morrie M. Gelfand, Elsa Wendman
Publikováno v:
Journal of Women's Health. 3:427-434
This study was undertaken to determine whether patients who have a history of breast cancer and who may experience vaginal dryness, vaginal irritation, or dyspareunia will benefit from application of a nonhormonal polycarbophil moisturizing gel. The
Autor:
Morrie M. Gelfand
Publikováno v:
Medical Science Symposia Series ISBN: 9780792359067
The term “menopause” is a key word for health professionals caring for the aging woman. It makes no difference whether you call it “change of life” or “climacteric” or “the change” or in fact “normal aging.” It is a fact of life t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b95dbbff10632d2ba585673f8a5dc67d
https://doi.org/10.1007/978-0-585-37973-9_27
https://doi.org/10.1007/978-0-585-37973-9_27
Autor:
Togas Tulandi, Morrie M. Gelfand
Publikováno v:
Androgens and Reproductive Aging
Foreword 1. Androgen production in women Natalie Z. Burger & Julia V. Johnson 2. Pathophysiology of androgen deficiency Gloria A. Bachmann & Margaret Kilibwa 3. Endocrine aspects of reproductive aging in men & women Ryan Zlupko & Joseph S. Sanfilippo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fb3a79ab52d5b5bc1f0948d5c00c180
https://doi.org/10.1201/b14632
https://doi.org/10.1201/b14632
Autor:
Michèle Moreau, John R. Hilditch, Morrie M. Gelfand, Normand Ayotte, Betty A Wong, Catherine Y Lau
Publikováno v:
Menopause (New York, N.Y.). 10(1)
OBJECTIVE The aim of this study was to evaluate the effects of a constant-estrogen, intermittent-progestogen hormone replacement regimen (Ortho-Prefest, Ortho-McNeil Pharmaceutical, Raritan, NJ, USA) on menopausal symptoms measured by the Kupperman I
Autor:
Morrie M. Gelfand
Publikováno v:
American journal of obstetrics and gynecology. 180(3 Pt 2)
For the patient who has had her ovaries and uterus removed, the acute onset of surgical menopause is of primary concern during the immediate postoperative period. The initiation of hormone replacement therapy at this time eliminates most symptoms tha
Publikováno v:
Obstetrics and gynecology. 90(1)
Objective To determine whether postmenopausal hormone therapy is associated with high-risk human papillomavirus (HPV) infection. Methods The detection rate of HPV DNA was studied in cellular residue from liquid-based collection tubes taken from 180 p
Autor:
Brinda Wiita, Morrie M. Gelfand
Publikováno v:
Clinical therapeutics. 19(3)
The endocrine physiology of the climacteric supports a rationale for the concomitant replacement of androgen and estrogen following menopause. Clinical and research experience with estrogen-androgen hormone replacement therapy, as well as androgen-on